CONTEXT THERAPEUTICS INC (CNTX) Stock Analyst Earnings Estimates
NASDAQ:CNTX - Nasdaq - US21077P1084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 513.33% | N/A 165.25% | N/A 155.57% | N/A 61.21% | |||||||||
| EBITDA YoY % growth | -33.19M | -24.04M 27.57% | N/A | N/A | N/A | -15.37M -43.23% | -25.061M -63.05% | -29.913M -19.36% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.23M | -24.06M 27.60% | -5.38M | -2.57M 52.23% | -10.53M -309.73% | -15.38M -46.06% | -25.073M -63.02% | -29.924M -19.35% | N/A -37.32% | N/A -15.24% | N/A -20.02% | N/A 22.04% | N/A 79.09% | N/A 828.76% | N/A 254.27% | N/A 82.29% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -0.93 90.13% | -1.50 -61.29% | -0.53 64.67% | N/A 53.00% | N/A -30.22% | N/A -13.21% | N/A -5.56% | N/A 91.24% | N/A 2,242.04% | N/A 265.90% | N/A 57.85% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 -56.06% | -0.07 68.84% | -0.07 -77.48% | -0.08 -60.49% | -0.24 -290.52% | -0.24 -257.14% | -0.26 -259.20% |
| Revenue Q2Q % growth | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.619M -114.30% | -7.08M 62.14% | -10.17M -135.93% | -8.262M -49.43% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.05 78.26% | -0.06 | 0.01 | 15.19% |
| Q4 2024 Q2Q % growth | -0.04 90.48% | -0.09 | 0.05 | 57.74% |
| Q3 2024 Q2Q % growth | -0.22 40.54% | -0.11 | -0.11 | -105.42% |
| Q2 2024 Q2Q % growth | -0.04 87.10% | -0.08 | 0.04 | 47.71% |
| Q1 2024 Q2Q % growth | -0.23 42.50% | -0.45 | 0.22 | 48.75% |
| Q4 2023 Q2Q % growth | -0.42 -90.91% | -0.36 | -0.06 | -17.65% |
| Q3 2023 Q2Q % growth | -0.37 -54.17% | -0.32 | -0.05 | -17.01% |
| Q2 2023 Q2Q % growth | -0.31 -24.00% | -0.20 | -0.11 | -51.96% |
| Q1 2023 Q2Q % growth | -0.40 -81.82% | -0.19 | -0.21 | -106.40% |
| Q4 2022 Q2Q % growth | -0.22 -5.21% | -0.30 | 0.08 | 26.89% |
| Q3 2022 Q2Q % growth | -0.24 | -0.26 | 0.02 | 5.88% |
| Q2 2022 Q2Q % growth | -0.25 | -0.26 | 0.01 | 1.96% |
| Q1 2022 Q2Q % growth | -0.22 | -0.24 | 0.02 | 10.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.49% | -5.97% | 0.43% | 9.69% |
| Revenue | N/A | N/A | N/A | N/A |